Scholay

学术搜索 · AI 审稿 · LaTeX 协作

Wante Lin

机构:Wenzhou Medical University, First Affiliated Hospital of Wenzhou Medical University

发表论文 21 篇 · 总被引 420 次 · h-index 10

代表论文

  • USP25 Ameliorates Pathological Cardiac Hypertrophy by Stabilizing SERCA2a in Cardiomyocytes (2023 · Circulation Research · 被引 129)
  • GSDMD (Gasdermin D) Mediates Pathological Cardiac Hypertrophy and Generates a Feed-Forward Amplification Cascade via Mitochondria-STING (Stimulator of Interferon Genes) Axis (2022 · Hypertension · 被引 51)
  • Podocyte OTUD5 alleviates diabetic kidney disease through deubiquitinating TAK1 and reducing podocyte inflammation and injury (2024 · Nature Communications · 被引 48)
  • Deubiquitinase JOSD2 improves calcium handling and attenuates cardiac hypertrophy and dysfunction by stabilizing SERCA2a in cardiomyocytes (2023 · Nature Cardiovascular Research · 被引 35)
  • DL-3-n-butylphthalide prevents oxidative stress and atherosclerosis by targeting Keap-1 and inhibiting Keap-1/Nrf-2 interaction (2022 · European Journal of Pharmaceutical Sciences · 被引 24)
  • Inhibition of TAK1/TAB2 complex formation by costunolide attenuates obesity cardiomyopathy via the NF-κB signaling pathway (2022 · Phytomedicine · 被引 19)